Boston Immune Technologies and Therapeutics
Biotechnology Research • 
Boston, Massachusetts, United States • 1-10 Employees
Company overview
| Headquarters | 50 Milk Street, Boston, Massachusetts 02110, US |
| Website | |
| NAICS | 541714 |
| SIC | 873 |
| Employees | 1-10 |
| Socials |
Key Contact at Boston Immune Technologies and Therapeutics
Russell Lamontagne
President and CEO
Boston Immune Technologies and Therapeutics Email Formats
Boston Immune Technologies and Therapeutics uses 1 email format. The most common is {first initial} (e.g., j@bostonimmunetech.com), used 100% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial} | j@bostonimmunetech.com | 100% |
About Boston Immune Technologies and Therapeutics
BITT has developed several proprietary TrapMAb monoclonal antibodies that have achieved or are rapidly approaching IND approval in oncology, autoimmunity, and neurodegeneration. TrapMAbs target the tumor necrosis factor receptor (TNFR) superfamily via a unique mechanism: they trap nascent TNFR molecules in an inactive hexagonal network. Compared to conventional monoclonals, these unique antagonists offer an efficacy advantage and, because they are selective for rapidly proliferating cells, TrapMAbs opens the door to TNFR superfamily targets that were previously considered undruggable or limited by toxicology.
Boston Immune Technologies and Therapeutics revenue & valuation
| Annual revenue | $427,775 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $1,400,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
Boston Immune Technologies and Therapeutics has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
Boston Immune Technologies and Therapeutics has never raised funding before.
Boston Immune Technologies and Therapeutics Tech Stack
Discover the technologies and tools that power Boston Immune Technologies and Therapeutics's digital infrastructure, from frameworks to analytics platforms.
CDN
Font scripts
JavaScript libraries
Miscellaneous
Programming languages
Security
Blogs
Page builders
Databases
Miscellaneous
Performance
Font scripts
United Kingdom
Italy
SpainFrequently asked questions
4.8
40,000 users
